CLB Quote, Financials, Valuation and Earnings

Barnwell Industries has a net margin of -0.13% compared to Core Laboratories's net margin of -33.82%. Core Laboratories's return on equity of 11.15% beat Barnwell Industries's return on equity of -47.42%.

Core Laboratories has a consensus price target of $15.60, signalling upside risk potential of 28.71%. On the other hand Barnwell Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Core Laboratories has higher upside potential than Barnwell Industries, analysts believe Core Laboratories is more attractive than Barnwell Industries.

Core Laboratories has a beta of 1.402, which suggesting that the stock is 40.205% more volatile than S&P 500. In comparison Barnwell Industries has a beta of -0.273, suggesting its less volatile than the S&P 500 by 127.266%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.33%. Barnwell Industries offers a yield of 0% to investors and pays a quarterly dividend of $0.02 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Barnwell Industries pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are larger than Barnwell Industries quarterly revenues of $3.6M. Core Laboratories's net income of -$154K is higher than Barnwell Industries's net income of -$1.2M. Notably, Core Laboratories's price-to-earnings ratio is 20.54x while Barnwell Industries's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.11x versus 1.04x for Barnwell Industries. Usually stocks with elevated PS ratios are considered overvalued.

CKX Lands has a net margin of -0.13% compared to Core Laboratories's net margin of 33.19%. Core Laboratories's return on equity of 11.15% beat CKX Lands's return on equity of 4.15%.

Core Laboratories has a consensus price target of $15.60, signalling upside risk potential of 28.71%. On the other hand CKX Lands has an analysts' consensus of -- which suggests that it could fall by --. Given that Core Laboratories has higher upside potential than CKX Lands, analysts believe Core Laboratories is more attractive than CKX Lands.

Core Laboratories has a beta of 1.402, which suggesting that the stock is 40.205% more volatile than S&P 500. In comparison CKX Lands has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.33%. CKX Lands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.98% of its earnings as a dividend. CKX Lands pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are larger than CKX Lands quarterly revenues of $348.2K. Core Laboratories's net income of -$154K is lower than CKX Lands's net income of $115.6K. Notably, Core Laboratories's price-to-earnings ratio is 20.54x while CKX Lands's PE ratio is 28.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.11x versus 12.72x for CKX Lands. Usually stocks with elevated PS ratios are considered overvalued.

Oceaneering International has a net margin of -0.13% compared to Core Laboratories's net margin of 7.47%. Core Laboratories's return on equity of 11.15% beat Oceaneering International's return on equity of 26.18%.

Core Laboratories has a consensus price target of $15.60, signalling upside risk potential of 28.71%. On the other hand Oceaneering International has an analysts' consensus of $20.50 which suggests that it could fall by -4.25%. Given that Core Laboratories has higher upside potential than Oceaneering International, analysts believe Core Laboratories is more attractive than Oceaneering International.

Core Laboratories has a beta of 1.402, which suggesting that the stock is 40.205% more volatile than S&P 500. In comparison Oceaneering International has a beta of 1.481, suggesting its more volatile than the S&P 500 by 48.108%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.33%. Oceaneering International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Oceaneering International pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are smaller than Oceaneering International quarterly revenues of $674.5M. Core Laboratories's net income of -$154K is lower than Oceaneering International's net income of $50.4M. Notably, Core Laboratories's price-to-earnings ratio is 20.54x while Oceaneering International's PE ratio is 12.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.11x versus 0.80x for Oceaneering International. Usually stocks with elevated PS ratios are considered overvalued.

Schlumberger has a net margin of -0.13% compared to Core Laboratories's net margin of 9.39%. Core Laboratories's return on equity of 11.15% beat Schlumberger's return on equity of 19.04%.

Core Laboratories has a consensus price target of $15.60, signalling upside risk potential of 28.71%. On the other hand Schlumberger has an analysts' consensus of $47.29 which suggests that it could grow by 31.69%. Given that Schlumberger has higher upside potential than Core Laboratories, analysts believe Schlumberger is more attractive than Core Laboratories.

Core Laboratories has a beta of 1.402, which suggesting that the stock is 40.205% more volatile than S&P 500. In comparison Schlumberger has a beta of 1.015, suggesting its more volatile than the S&P 500 by 1.515%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.33%. Schlumberger offers a yield of 3.12% to investors and pays a quarterly dividend of $0.29 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Schlumberger pays out 34.37% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are smaller than Schlumberger quarterly revenues of $8.5B. Core Laboratories's net income of -$154K is lower than Schlumberger's net income of $797M. Notably, Core Laboratories's price-to-earnings ratio is 20.54x while Schlumberger's PE ratio is 12.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.11x versus 1.41x for Schlumberger. Usually stocks with elevated PS ratios are considered overvalued.